| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |